Home
/
AtriCure, Inc.
/
Financials
/
Quarterly
AtriCure, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AtriCure, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2018
Jun 30, 2018
$51.80M
Aug 2, 2018
Q1
2018
Mar 31, 2018
$46.99M
Apr 27, 2018
Q3
2017
Sep 30, 2017
$42.15M
Nov 2, 2017
Q2
2018
Jun 30, 2017
$45.23M
Aug 2, 2018
Q1
2018
Mar 31, 2017
$41.27M
Apr 27, 2018
Q3
2017
Sep 30, 2016
$38.34M
Nov 2, 2017
Q2
2017
Jun 30, 2016
$39.67M
Jul 28, 2017
Q1
2017
Mar 31, 2016
$35.94M
May 5, 2017
Q3
2016
Sep 30, 2015
$31.42M
Oct 28, 2016
Q2
2016
Jun 30, 2015
$32.58M
Aug 5, 2016
Q1
2016
Mar 31, 2015
$29.89M
Apr 29, 2016
Q3
2015
Sep 30, 2014
$26.68M
Oct 30, 2015
Q2
2015
Jun 30, 2014
$26.51M
Jul 31, 2015
Q1
2015
Mar 31, 2014
$24.85M
May 1, 2015
Q3
2014
Sep 30, 2013
$20.15M
Oct 31, 2014
Q2
2014
Jun 30, 2013
$20.43M
Jul 30, 2014
Q1
2014
Mar 31, 2013
$19.43M
Apr 30, 2014
Q3
2013
Sep 30, 2012
$16.14M
Nov 1, 2013
Q2
2013
Jun 30, 2012
$18.27M
Aug 2, 2013
Q1
2013
Mar 31, 2012
$17.48M
May 3, 2013
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$134.27M
Oct 30, 2025
Q2
2025
Jun 30, 2025
$136.14M
Jul 30, 2025
Q1
2025
Mar 31, 2025
$123.62M
Apr 30, 2025
Q3
2025
Sep 30, 2024
$115.91M
Oct 30, 2025
Q2
2025
Jun 30, 2024
$116.27M
Jul 30, 2025
Q1
2025
Mar 31, 2024
$108.85M
Apr 30, 2025
Q3
2024
Sep 30, 2023
$98.29M
Oct 30, 2024
Q2
2024
Jun 30, 2023
$100.92M
Jul 31, 2024
Q1
2024
Mar 31, 2023
$93.49M
May 2, 2024
Q3
2023
Sep 30, 2022
$83.25M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$84.53M
Jul 26, 2023
Q1
2023
Mar 31, 2022
$74.58M
May 3, 2023
Q1
2022
Dec 31, 2021
$73.22M
May 4, 2022
Q3
2022
Sep 30, 2021
$70.46M
Nov 2, 2022
Q1
2022
Sep 30, 2021
$70.46M
May 4, 2022
Q2
2022
Jun 30, 2021
$71.38M
Aug 3, 2022
Q1
2022
Jun 30, 2021
$71.38M
May 4, 2022
Q1
2022
Mar 31, 2021
$59.28M
May 4, 2022
Q3
2021
Sep 30, 2020
$54.76M
Nov 4, 2021
Q2
2021
Jun 30, 2020
$40.82M
Aug 5, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($267.0K)
Oct 30, 2025
Q2
2025
Jun 30, 2025
($6.19M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($6.75M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($7.85M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($8.01M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($13.27M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($9.06M)
Oct 30, 2024
Q2
2024
Jun 30, 2023
($5.12M)
Jul 31, 2024
Q1
2024
Mar 31, 2023
($6.48M)
May 2, 2024
Q3
2023
Sep 30, 2022
($12.27M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($14.84M)
Jul 26, 2023
Q1
2023
Mar 31, 2022
($15.18M)
May 3, 2023
Q3
2022
Sep 30, 2021
$97.11M
Nov 2, 2022
Q2
2022
Jun 30, 2021
($16.25M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($16.92M)
May 4, 2022
Q3
2021
Sep 30, 2020
($4.95M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($8.24M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($16.41M)
Apr 28, 2021
Q3
2020
Sep 30, 2019
($9.36M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($4.10M)
Jul 29, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$208.0K
Oct 30, 2025
Q2
2025
Jun 30, 2025
($6.19M)
Jul 30, 2025
Q1
2025
Mar 31, 2025
($5.95M)
Apr 30, 2025
Q3
2025
Sep 30, 2024
($7.41M)
Oct 30, 2025
Q2
2025
Jun 30, 2024
($7.17M)
Jul 30, 2025
Q1
2025
Mar 31, 2024
($10.92M)
Apr 30, 2025
Q3
2024
Sep 30, 2023
($8.09M)
Oct 30, 2024
Q2
2024
Jun 30, 2023
($4.14M)
Jul 31, 2024
Q1
2024
Mar 31, 2023
($5.78M)
May 2, 2024
Q3
2023
Sep 30, 2022
($10.72M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($13.66M)
Jul 26, 2023
Q1
2023
Mar 31, 2022
($14.15M)
May 3, 2023
Q3
2022
Sep 30, 2021
$98.67M
Nov 2, 2022
Q2
2022
Jun 30, 2021
($15.08M)
Aug 3, 2022
Q1
2022
Mar 31, 2021
($15.89M)
May 4, 2022
Q3
2021
Sep 30, 2020
($3.99M)
Nov 4, 2021
Q2
2021
Jun 30, 2020
($7.29M)
Aug 5, 2021
Q1
2021
Mar 31, 2020
($15.45M)
Apr 28, 2021
Q3
2020
Sep 30, 2019
($8.64M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($3.84M)
Jul 29, 2020